menu

Rethinking Benzoyl Peroxide in Acne and Rosacea

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Rethinking Benzoyl Peroxide in Acne and Rosacea

4 chapters
Play All
0.25 credits
15 minutes
Chapter 1
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Take Post-TestSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.25 credits
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    Do you ever wish you could mix the unmixable when it comes to treatment selection? Microencapsulation is the answer! This new technology preserves the advantages of BPO while minimizing limitations for patients with acne and rosacea. Tune in to our chapterized panel discussion with Drs. Linda Stein Gold, Julie Harper, and Neal Bhatia and view 3D animation revealing how microencapsulation works.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Linda Stein Gold, MD
    Director of Clinical Research
    Henry Ford Hospital
    Department of Dermatology
    Detroit, MI

    Consulting Fees: Dermavant Sciences, Inc., Incyte, Leo Pharma, Mayne Pharma, Ortho Dermatologics, Sun Pharma, Taro Pharmaceutical Industries; and a consultant
    Commercial Interest Speakers Bureau: Leo Pharma

    Faculty:
    Neal Bhatia, MD
    Therapeutics Clinical Research
    San Diego, CA
    Associate Clinical Professor, Harbor-UCLA Medical Center
    Los Angeles, CA

    Consulting Fees: Almirall, Biofrontera AG, Castle Biosciences, Dermavant Sciences, DermTech Inc., EPI Health, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., ISDIN, La Roche-Posay Laboratorie Pharmaceutique, Mayne Pharma Group, Ortho Dermatologics, Sanofi/Regeneron, Sonoma Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Vyome Therapeutics Limited
    Contracted Research: AbbVie, Amgen, Arcutis, Inc., Atacama Therapeutics, Brickell Biotech, Inc., Bristol-Myers Squibb, Dermira, Dr. Reddy's Laboratories Ltd., DUSA Pharmaceuticals, Inc., Foamix, LEO Pharma, US, MC2 Therapeutics, Menlo Therapeutics, Pfizer Inc., Sanofi/Regeneron, Sol-Gel Technologies, Soligenix, Inc, Sun Pharmaceutical Industries Ltd., UCB, Vyome Therapeutics Limited

    Julie C. Harper, MD
    Dermatology and Skin Care Center of Birmingham
    Department of Dermatology
    University of Alabama at Birmingham
    Birmingham, AL

    Commercial Interest Speakers Bureau: Almirall, EPI, Galderma, Ortho, Vyne
    Consulting Fees: Almirall, BioPharmX, Cassiopeia, Cutanea, Cutera, Dermira, EPI, Galderma, LaRoche-Posay, Ortho, Sol Gel, Sun, Vyne

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Libby Lurwick has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Recognize the mechanism of action and benefits of benzoyl peroxide alone and in combination with retinoids
    • Describe the mechanisms and clinical benefits of microencapsulation formulations of topical treatments for acne and rosacea
    • Describe the mechanisms by which benzoyl peroxide decreases inflammation and inhibits the development of resistance by C. acnes
  • Target Audience

    This activity is designed to meet the educational needs of dermatologists, dermatology mid-level providers, and other HCPs specializing in acne and rosacea.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .25 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.

  • Commercial Support

    This activity is supported by an independent educational grant from Galderma Laboratories, L.P.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    Do you ever wish you could mix the unmixable when it comes to treatment selection? Microencapsulation is the answer! This new technology preserves the advantages of BPO while minimizing limitations for patients with acne and rosacea. Tune in to our chapterized panel discussion with Drs. Linda Stein Gold, Julie Harper, and Neal Bhatia and view 3D animation revealing how microencapsulation works.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Linda Stein Gold, MD
    Director of Clinical Research
    Henry Ford Hospital
    Department of Dermatology
    Detroit, MI

    Consulting Fees: Dermavant Sciences, Inc., Incyte, Leo Pharma, Mayne Pharma, Ortho Dermatologics, Sun Pharma, Taro Pharmaceutical Industries; and a consultant
    Commercial Interest Speakers Bureau: Leo Pharma

    Faculty:
    Neal Bhatia, MD
    Therapeutics Clinical Research
    San Diego, CA
    Associate Clinical Professor, Harbor-UCLA Medical Center
    Los Angeles, CA

    Consulting Fees: Almirall, Biofrontera AG, Castle Biosciences, Dermavant Sciences, DermTech Inc., EPI Health, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., ISDIN, La Roche-Posay Laboratorie Pharmaceutique, Mayne Pharma Group, Ortho Dermatologics, Sanofi/Regeneron, Sonoma Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Vyome Therapeutics Limited
    Contracted Research: AbbVie, Amgen, Arcutis, Inc., Atacama Therapeutics, Brickell Biotech, Inc., Bristol-Myers Squibb, Dermira, Dr. Reddy's Laboratories Ltd., DUSA Pharmaceuticals, Inc., Foamix, LEO Pharma, US, MC2 Therapeutics, Menlo Therapeutics, Pfizer Inc., Sanofi/Regeneron, Sol-Gel Technologies, Soligenix, Inc, Sun Pharmaceutical Industries Ltd., UCB, Vyome Therapeutics Limited

    Julie C. Harper, MD
    Dermatology and Skin Care Center of Birmingham
    Department of Dermatology
    University of Alabama at Birmingham
    Birmingham, AL

    Commercial Interest Speakers Bureau: Almirall, EPI, Galderma, Ortho, Vyne
    Consulting Fees: Almirall, BioPharmX, Cassiopeia, Cutanea, Cutera, Dermira, EPI, Galderma, LaRoche-Posay, Ortho, Sol Gel, Sun, Vyne

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Libby Lurwick has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Recognize the mechanism of action and benefits of benzoyl peroxide alone and in combination with retinoids
    • Describe the mechanisms and clinical benefits of microencapsulation formulations of topical treatments for acne and rosacea
    • Describe the mechanisms by which benzoyl peroxide decreases inflammation and inhibits the development of resistance by C. acnes
  • Target Audience

    This activity is designed to meet the educational needs of dermatologists, dermatology mid-level providers, and other HCPs specializing in acne and rosacea.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .25 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.

  • Commercial Support

    This activity is supported by an independent educational grant from Galderma Laboratories, L.P.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule18 May 2022
Webpack App